沙美特罗替卡松粉吸入剂联合噻托溴铵粉吸入剂对哮喘患者炎症因子及免疫功能的影响
Zhejiang Journal of Integrated Traditional Chinese and Western Medicine（2021）
Abstract
近年来,随着吸入性糖皮质激素和其他控制哮喘药物的发展,支气管哮喘简称哮喘(bronchial asthma)的治疗取得了长足进步[1].本研究观察沙美特罗替卡松粉(商品名:舒利迭)联合噻托溴铵粉吸入剂治疗哮喘的疗效以及对其炎症因子和细胞及体液免疫功能的影响,现报道如下.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined